Informations générales (source: ClinicalTrials.gov)
National Lymphangioleiomyomatosis Registry, France (RE-LAM-CE)
Observational
Vincent COTTIN (Voir sur ClinicalTrials)
janvier 2012
décembre 2026
05 avril 2025
RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to
determine the incidence and prevalence of lymphangioleiomyomatosis in France, including
demographic information and information concerning the timing and modalities of
diagnosis.
Based on the registry, we will set up a prospective cohort of patients. The database will
include detailed medical information, particularly regarding progression of the
respiratory function.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hôpital Louis Pradel - 69677 - Lyon - France | Vincent Cottin, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous
sclerosis.
- patients diagnosed or hospitalized or seen in consultation since 01/01/2008
- Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous
sclerosis.
- patients diagnosed or hospitalized or seen in consultation since 01/01/2008
- None